ICON is a global provider of outsourced development services
Products and services
ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology, medical device and government and public health organisations to bring new treatments to market faster. Our services span the entire lifecycle of product development, across a broad range of therapeutic areas, and can be adapted to suit small local trials or large global programs. We develop integrated technologies to significantly enhance the efficiency and productivity of clients’ drug and device development programs.
Facts and Figures
- Financial information: Full year reported revenue for 2018 was $2,595.8 million. Excluding the impact of ASC 606, full year revenue increased to $1,897.6 million from $1,758.4 million in 2017, an increase of 7.9%. Revenue guidance for full year 2019 is in the range of $2,790 - $2,830 million (see Q3 earnings release).
- Employee numbers: ICON currently has 14,600 employees in 99 locations in 40 countries.